Axon Regeneration in Young Adult Mice Lacking Nogo-A/B  by Kim, Ji-Eun et al.
Neuron, Vol. 38, 187–199, April 24, 2003, Copyright 2003 by Cell Press
Axon Regeneration in Young Adult Mice
Lacking Nogo-A/B
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identified in CNS myelin. Experimentally induced ab-Department of Neurobiology
sence of myelin promotes axon regeneration (Savio andYale University School of Medicine
Schwab, 1990), and myelin-forming oligodendrocytesNew Haven, Connecticut 06510
inhibit axon growth in vitro (Bandtlow et al., 1990). My-
elin-associated glycoprotein (MAG) is one protein that
inhibits axon outgrowth in vitro (Mukhopadhyay et al.,
Summary 1994; McKerracher et al., 1994). In vivo, MAG has been
shown to limit axon regeneration under certain condi-
After injury, axons of the adult mammalian brain and tions (Scha¨fer et al., 1996), although regeneration gener-
spinal cord exhibit little regeneration. It has been sug- ally remains poor in the absence of MAG (Bartsch et al.,
gested that axon growth inhibitors, such as myelin- 1995). The physiologic function of MAG appears not to
derived Nogo, prevent CNS axon repair. To investigate be the limitation of axon growth, but rather participation
this hypothesis, we analyzed mice with a nogo muta- in myelin stability by axoglial contact. Mice lacking MAG
tion that eliminates Nogo-A/B expression. These mice have delayed myelination, myelin splitting and redun-
are viable and exhibit normal locomotion. Corticospi- dancy, and decreased thickness of the periaxonal cyto-
nal tract tracing reveals no abnormality in uninjured plasmic collar of oligodendrocytes (Li et al., 1994; Mon-
nogo-A/B/ mice. After spinal cord injury, corticospi- tag et al., 1994). Over time, these myelin changes are
nal axons of young adult nogo-A/B/ mice sprout ex- associated with axonal degeneration (Fruttiger et al.,
tensively rostral to a transection. Numerous fibers re- 1995).
generate into distal cord segments of nogo-A/B/ Another myelin-derived axon growth inhibitor is Nogo
mice. Recovery of locomotor function is improved in or Reticulon 4 (reviewed by GrandPre´ and Strittmatter,
these mice. Thus, Nogo-A plays a role in restricting 2001). Analysis of the nogo expression reveals three
axonal sprouting in the young adult CNS after injury. mRNA species derived from two promotors and alterna-
tive splicing (GrandPre´ et al., 2000; Chen et al., 2000;
Prinjha et al. 2000). Nogo-A is the major protein speciesIntroduction
in oligodendrocytes, with little or no Nogo-C in these
cells and myelin (GrandPre´ and Strittmatter, 2001; WangAxotomized peripheral axons exhibit a robust regenera-
et al., 2002a; Huber et al., 2002). Both Nogo-C andtive reaction after axotomy. In stark contrast, severed
Nogo-A are also found in neurons, while skeletal musclebrain and spinal axons do not advance through the adult
produces Nogo-A embryonically and Nogo-C in theCNS. Instead, these fibers are trapped at the site of
adult. Nogo-B is a minor form in brain. A 66 aa domaindamage and remain disconnected from synaptic tar-
common to all Nogo forms is expressed on the surfacegets, leading to profound and persistent deficits in many
of oligodendrocytes (GrandPre´ et al., 2000) and can po-clinical cases. Spinal cord injury (SCI) is the clearest
tently inhibit axonal outgrowth by binding to an axonalexample of a condition in which axonal disconnection
Nogo-66 receptor (NgR; Fournier et al., 2001). A secondleads to significant disability despite minimal neuronal
amino-terminal domain of Nogo-A may also contributedeath.
to axon outgrowth inhibition by an undefined mecha-
In part, the CNS/PNS axonal regenerative disparity
nism (Fournier et al., 2001). There appears to be a conflu-
can be explained by the selective capacity of peripheral
ence of myelin inhibitory effects at the axonal NgR. Our
neurons to express a gene repertoire after axotomy that investigations of NgR signaling mechanisms led to the
promotes growth (Skene, 1989; Neumann and Woolf, realization that the NgR is a functional receptor for MAG
1999; Bonilla et al., 2002). However, several lines of as well as for Nogo-66 (Liu et al., 2002). Oligodendrocyte
evidence have suggested that the explanation for poor myelin glycoprotein (OMgp), a third CNS myelin-derived
CNS axon regeneration is not cell autonomous. In partic- axon growth inhibitor, also acts through the NgR (Wang
ular, the studies of Aguayo and colleagues demonstrate et al., 2002b).
long-distance growth of adult CNS axons in an appro- The in vitro activity of Nogo-66 and the selective ex-
priate environment, such as a sciatic nerve transplant pression of Nogo in CNS but not PNS myelin are consis-
(David and Aguayo, 1981; Benfey and Aguayo, 1982). tent with a role as a myelin-derived inhibitor of axonal
Inhibitors of axon growth have been identified in the regeneration after injury (GrandPre´ et al., 2000). In sup-
injured CNS. Astroglial scars at sites of damage produce port of this hypothesis, the IN-1 antibody, recognizing
chondroitin sulfate proteoglycans and inhibit axonal Nogo and several other antigens, can promote CNS
growth locally (Davies et al., 1999; Fawcett and Asher, axon sprouting after injury (Bregman et al., 1995; re-
1999). Indeed, recent data indicate that digestion of viewed by Bandtlow and Schwab, 2000). Similarly, but
chondroitin sulfates can lead to axonal sprouting and more selectively, a fragment of Nogo-66 with NgR antag-
onist properties enhances axonal regeneration after SCI
(GrandPre´ et al., 2002). However, a role for Nogo in*Correspondence: stephen.strittmatter@yale.edu
1These authors contributed equally to this work. limiting CNS axonal regeneration has not been examined
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Figure 1. Disruption of the Mouse nogo Locus by Retroviral Gene-Trapping
(A) Diagram of the retroviral insertion. A restriction map illustrates the native exons of the mouse nogo gene and insertion of the 8.0 kb
retroviral vector VICTR37 (not shown to scale) into the longest exon specific for Nogo-A.
(B) Southern blot and PCR analyses of Nhe I-digested genomic DNA from nogo-A/B/, nogo-A/B/, and nogo-A/B/ mice. Hybridization
with a PCR-amplified probe fragment (shown in A) yields an 8–9 kb wild-type band and a shorter 3 kb fragment from the disrupted gene.
The bottom panel illustrates agarose gel separation of typical PCR reaction products from mouse genotyping.
(C) Northern blot analysis for nogo, ngr, and -actin mRNA in the brains of nogo-A/B/ and nogo-A/B/ mice. The top left panel is from
hybridization with a 3 nogo probe detecting nogo-A, -B, and -C, as indicated. The top right panel is from hybridization with a 5 nogo-A
probe. The low-level expression of two novel transcripts from the mutated locus is demonstrated (trap 1, trap 2). Size markers are shown
between the two panels.
(D) Immunoblot analysis for Nogo-A protein expression in total brain lysate and purified myelin extract from the brains of nogo-A/B/, nogo-
A/B/, and nogo-A/B/ mice. Myelin-associated glycoprotein (MAG) and myelin basic protein (MBP) were used as control myelin proteins.
(E) Anti-Nogo-A/B immunoblot in brain and lung lysates from nogo-A/B/, nogo-A/B/, and nogo-A/B/ mice. Note the clear Nogo-B band
in wild-type lung that is absent from the homozygous mutant mouse sample. No novel protein species of lesser molecular size containing
the Nogo-A/B amino terminus are detected in the nogo-A/B/ samples. Molecular size markers are shown at right.
with genetic methods. Here, we have analyzed mice transcripts are expected to contain the geo sequence
and to be slightly larger than endogenous nogo-Alacking Nogo-A protein. The analysis reveals a role for
Nogo-A in limiting axonal growth after axotomy in the mRNA, but they should lack sequences from the 3 end
of nogo that are common to all splice forms. Northernadult CNS.
analysis with a probe from the 3 common nogo region
demonstrates a complete absence of nogo-A mRNA inResults
the adult brain of homozygous nogo-A/B/ mice (Figure
1C). The mRNA level for nogo-B in the adult brain ofMice Lacking Nogo-A/B Are Viable
Embryonic stem cell lines in which the nogo gene had wild-type mice is quite low, and it is absent from the
nogo-A/B/mice. The nogo-C and ngr expression levelsbeen “trapped” were identified from sequences of the
trapped exons (Zambrowicz et al., 1998). A mouse strain are unchanged in this nogo gene trap line. A probe
derived from the 5 end of nogo corresponding to aaestablished from these cells by blastocyst injection is
viable in the homozygous state and selectively disrupts 30–145 encoded in exon 1 also demonstrates the ab-
sence of wild-type nogo-A transcripts in the nogo-A/nogo-A and nogo-B expression. The gene trap insertion
site maps near the 5 end of the largest nogo-A-selective B/ brain. This 5 nogo-A probe detects a relatively
low level of at least two larger mRNA species that areexon (Figures 1A and 1B). Based on the gene trap design
and the insertion site, it is predicted that both nogo-A consistent withgeo fusion species derived from normal
nogo-A splicing and from splicing of exon1 to the strongand nogo-B, but not nogo-C, expression will be dis-
rupted by this insertion. Disrupted nogo-A and nogo-B splice acceptor of the inserted DNA. Both forms are
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expected to terminate at the polyadenylation sequence Of course, Nogo-A expression and function in oligo-
dendrocytes is of the greatest interest. Luxol fast blueof the insert. The relatively reduced level of these novel
mutated mRNA species is consistent with the insertion stains for total myelin content and location demonstrate
normal patterns in young adult mice lacking Nogo-Areducing either nogo transciption or nogo-geo fusion
mRNA stability. (Figures 2G and 2H). Biochemically, myelin can be pre-
pared from density gradient centrifugation in equal yieldNogo-A protein of 205 kDa can be detected in the
adult brain and in myelin preparations of wild-type mice from wild-type, nogo-A/B/, and nogo-A/B/ mice
(data not shown). Furthermore, such myelin prepara-with an antibody directed against a peptide encoded
by a nogo-A-specific sequence 3 to the location of the tions from mice of different genotype contain equal
levels of MAG and myelin basic protein (Figure 1D).gene trap insertion site. Nogo-A is absent from the nogo-
A/B/ brain (Figure 1D). A second antiserum directed -galactosidase-positive cells are visualized in the cor-
pus callosum and deep cerebellar white matter with aagainst the most amino-terminal region of Nogo-A and
-B fails to detect significant levels of Nogo-B in the brain, location and distribution consistent with oligodendro-
cytes (Figures 2F and 2I). Qualitatively, the density andbut does demonstrate the presence of 51 kDa Nogo-B
in wild-type lung tissue by immunoblot. In the nogo-A/ position of these -galactosidase-positive cells is simi-
lar to that of CNPase-positive oligodendrocytes in wild-B/ lung, Nogo-B is absent (Figure 1E). The mutated
nogo-geo hybrid RNA has the potential to encode a type mice. Thus, oligodendrocyte formation and survival
appears normal in the absence of Nogo-A. The -galac-truncated Nogo-A terminating at aa 309 and lacking both
the Nogo-66 and the Amino-Nogo inhibitory domains. tosidase expression demonstrates that the mutant chi-
meric nogo-geo mRNA is stable enough to produceContingent on the stability of the hydrophilic truncated
Nogo-A 1–309 fragment, it might be produced as a solu- some detectable -galactosidase protein within oligo-
dendrocytes.ble cytoplasmic protein. The strong splice acceptor of
the construct is expected to trap erstwhile nogo-B tran- Despite the normal appearance of these histologic
parameters, the absence of Nogo-A might change neu-scripts so that a 1–168 aa protein might be formed in
Nogo-B-producing cells. However, immunoblots of ronal function and mouse behavior through effects on
axonal performance. Qualitative neurological examina-brain and lung with an amino-terminal directed anti-
Nogo-A/B antibody fail to demonstrate any significant tion of the mice lacking Nogo-A reveals no deficits in
function. Open-field behavioral parameters were not sig-level of a novel smaller protein species (Figure 1E). This
is likely due to reduced levels of the nogo-geo hybrid nificantly different from littermate control mice (Figure
2J). There was a slight, but nonsignificant, trend towardmRNA as compared to wild-type nogo-A and due to
the truncated protein instability. We conclude that this decreased time in the center of an open field for the
nogo-A/B/ mice, a characteristic taken to correlatemutation in nogo effectively eliminates the expression
of both Nogo-A and Nogo-B, but not Nogo-C. with measures of increased anxiety in other rodent ex-
periments. The rotarod test assesses motor coordina-On a mixed 129/C57Bl6J background, mice of the
nogo-A/B/ genotype are born at expected Mendelian tion and learning. No differences between mice with and
without Nogo-A are observed on this test (Figure 2K).frequencies and grow with normal body weights. Both
males and females are fertile. No unexpected deaths The BBB score is another measure of locomotor function
in the open field and is commonly used to assess deficitshave been witnessed in homozygous animals up to 12
months of age. after SCI (Basso et al., 1996). The uninjured nogo-A/B/
mice exhibited a full range score of 21, similar to controls
(data not shown). Overall, routine anatomical and loco-Normal Brain Histology and Behavior
motor analysis demonstrates no deficits in the nogo-in Nogo-A Null Mice
A/B null mice.Nogo-A, but not NgR, is distributed in many cell types of
the developing CNS prior to oligodendrocyte maturation
(Wang et al., 2002a). Therefore, Nogo-A could conceiv- CNS Myelin Lacking Nogo-A/B Does Not Inhibit
Axonal Outgrowthably play a critical role in CNS patterning independent
of NgR and myelin/axon interactions (Wang et al., 2002a; It is known that CNS myelin and Nogo-A can inhibit
axonal growth in vitro. To determine whether Nogo-A isHuber et al., 2002). However, brain size and gross anat-
omy are normal in adult nogo-A/B/ mice; there is no responsible for a significant fraction of myelin-depen-
dent inhibition, we examined wild-type axons in thewidespread failure of early developmental events. Major
brain nuclei and the neuronal layers of the cerebral cor- presence of myelin prepared from wild-type or nogo-A/
B/ or nogo-A/B/ mice (Figure 3). All three prepara-tex and cerebellum are indistinguishable from those of
wild-type mice by hematoxylin and eosin staining (Fig- tions contain equal concentrations of MAG and MBP,
differing only in Nogo-A concentration (Figure 1D). Wild-ures 2A, 2B, 2D, and 2E). Because the nogo gene inser-
tion places lacZ under the control of the nogo-A regula- type or nogo-A/B/ myelin potently collapses DRG
growth cones, but nogo-A/B/ myelin is 10 to 100 timestory elements (Figure 1A), those cells that would
normally express Nogo-A can be identified by staining less potent in this assay as a collapsing agent (Figures
4A and 4B). Chronic exposure to a substratum coatedfor -galactosidase activity. In the cerebral cortex, the
number and position of -galactosidase-positive cells with wild-type CNS myelin inhibits neurite outgrowth.
Eight-fold higher concentrations of myelin lacking(Figure 2C) is very similar to Nogo-A-positive cells in
wild-type mice (GrandPre´ et al., 2000; Wang et al., Nogo-A are required to achieve the same level of inhibi-
tion (Figures 3A and 3C). This effect is more dramatic2002a). The data indicate that neuronal placement and
survival is normal in adult nogo-A/B/ mice. than that of the NEP1-40 peptide, which selectively
Neuron
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Figure 2. General Brain Histology and Loco-
motor Activity in nogo-A/B/ Mice
(A–C) Coronal sections through the cerebral
cortex stained with hematoxylin and eosin (A
and B) or X-gal (C).
(D, E, and G–I) Parasagittal sections through
the cerebellum stained with hematoxylin and
eosin (D and E), Luxol fast blue (G and H), or
X-gal (I).
(F) Corpus callosum in coronal sections
stained with X-gal.
Scale bars equal 200 m (A–E) and 50 m
(F–I).
(J) Open-field activity. Floor plane sensor
measurements collected from an automated
activity monitoring cage for nogo-A/B/ mice
shown as a percent of nogo-A/B/ mice.
(K) Rotarod test. The time that mice were able
to remain on the rotating rod at constantly
accelerating speeds is reported.
blocks Nogo-66 action (GrandPre´ et al., 2002), arguing amine (BDA) injections (Figures 5A–5E). Tissue was col-
lected 18–21 days after SCI. In wild-type littermate miceeither that both Nogo-66 and Amino-Nogo have a role
in myelin inhibition or that pharmacologic blockade is (data not shown) or in nogo-A/B/ control mice, the
dorsal CST (dCST) is tightly bundled at the base of theless than 100% effective for Nogo-66. Similar results
were observed in postnatal mouse cerebellar neurons contralateral dorsal columns rostral to the lesion site at
T3 (Figures 4A and 4B). A smaller percentage (3% orand in adult mouse DRG cultures (Figure 3D). At high
concentrations, it is clear that nogo-A/B/ myelin pos- 15/mouse) of CST fibers are observed in the crossed
dorsolateral CST (dlCST) and uncrossed ventral CSTsesses inhibitory activity. We considered whether this
might be attributable to MAG. Residual myelin inhibitory (vCST;0.5% or 2/mouse). A dramatically different pat-
tern is seen rostral to the spinal cord hemisection in theactivity is blocked by anti-MAG antibodies (Figure 3E).
Thus, Nogo-A, and secondarily MAG, accounts for a littermate nogo-A/B/ mice (Figures 4B and 4D). The
dCST is normally positioned, but numerous CST fibersmajority of axon inhibitory activity in CNS myelin prepa-
rations. are detected in the lateral funiculus on the side ipsilateral
to the cortical BDA injection. The total number of fibers
outside of the dCST is increased nearly 10-fold in theCorticospinal Tract Sprouting after SCI
in nogo-A/B/ Mice nogo-A/B/ mice (Figure 4F). More specifically, the
number of fibers ipsilateral to the injection is increasedTo consider what effect the lack of myelin-dependent
axon inhibition might have on axonal regeneration after nearly 100-fold in the absence of Nogo-A. All 8 of 8
control mice of 7.5–9 weeks of age at the time of injuryCNS axotomy, we performed dorsal hemisection injuries
at T6 in nogo-A/B/ mice. The descending corticospinal had three or fewer CST fibers in the lateral funiculus
ipsilateral to the injection site, while 12/12 of similarlytract (CST) was visualized by cortical biotin-dextran
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aged nogo-A/B/ mice had greater than this number, fiber growth in the rostral-caudal region of the injury
(Figures 5E–5K). No dCST fibers extend past a dorsalwith an average of 117 fibers. Only three older (11–14
weeks at injury) nogo-A/B/ mice were examined, but hemisection in wild-type or nogo-A/B/ mice (Figures
5E and 5F). In five nogo-A/B/ mice, the pattern of CSTthere was a trend to less pronounced sprouting, with
an average of seven ectopic fibers per animal. Mice of fiber sprouting around and past the lesion is extensive
(Figures 5G–5K).both age groups are included in the statistical analysis
(Figure 4F). Densitometric analysis confirmed the eleva- Regenerating CST fibers are seen in transverse spinal
cord sections more than 5 mm caudal to the hemisectiontion of BDA labeling in the ipsilateral lateral funiculus
(Figure 4G). (Figure 6). While occasional uninjured vCST or lateral
fibers are seen in hemisected wild-type or nogo-A/B/The ipsilateral fibers observed in the hemisected
nogo-A/B/ mice might reflect a developmental malfor- mice at this level, the average CST axon number is 40-
fold greater in the nogo-A/B/ mice, and 7 of 11 micemation or a response to injury. To assess this possibility,
BDA was injected into uninjured mice and the CST was of 7.5–9 weeks at injury exhibited fiber counts outside
the range of control mice (Figure 6F). A majority of thetraced. The uninjured nogo-A/B/ mice exhibit a trend
toward increased contralateral fibers outside of the regenerating CST fibers in Nogo-A null mice are de-
tected bilaterally in the lateral white matter of the corddCST, but this does not reach statistical significance
(Figure 4F). Clearly, the 100-fold increase in CST fibers (Figures 6B and 6D). Few or no regenerating fibers are
observed in the normal position of the CST, the dorsalin the lateral cord ipsilateral to the cortical injection
occurs only with the combination of injury plus the nogo- column. Densitometric analysis of HRP labeling of BDA-
containing fibers in the lateral columns confirms theA/B/ mutation. These fibers might derive from de-
scending fibers that sprout at the pyramidal decussation increased axon number in the nogo-A/B/ mice (Figure
6G). Three nogo-A/B/ mice underwent surgery atand then traverse the ipsilateral cord in a direct path,
or from collaterals of the dCST that preferentially recross 11–14 weeks of age. In this small group, proximal sprout-
ing was less prominent and no CST fibers regeneratedthe midline to assume a position ipsilateral to the BDA
injection. Examination of the medulla and the pyramidal to a distance 5 mm below the injury site (Figure 6F).
Overall, long-distance axonal regeneration is prominentdecussation at the cervicomedullary junction does not
reveal any obvious abnormality in the hemisected nogo- in a majority of the nogo-A/B/ mice examined.
A/B/ mice (data not shown). Instead, there is a gradual
increase in the number of ectopic CST fibers in a pro- Improved Locomotor Recovery after SCI
gression from rostral to caudal in the spinal cord, with in nogo-A/B/ Mice
greatest numbers near the injury site (Figure 4H). While We considered whether the extensive long-distance ax-
single fibers could not be traced for long distances in onal regeneration in the nogo-A/B/ mice is correlated
these preparations, the simplest explanation for the ob- with functional recovery after this midthoracic dorsal
served CST fibers is a steady increase in collateral hemisection injury. Recovery was assessed using a
sprouting closer to the axotomy site with a preference standardized open-field measure of locomotor function
of sprouted fibers to recross the spinal cord. A number of after SCI, the BBB score. In this scale, 21 is normal
CST fibers can be seen crossing the midline immediately function and 0 is bilateral total paralysis of the hindlimbs.
dorsal to the central canal of the spinal cord in hemi- All mice had scores of 3 or less at 4 hr post injury (data
sected nogo/ mice rostral to the injury (Figure 4E). The not shown). The nogo-A/B/ mice gradually recover
data demonstrate a pronounced CNS axonal sprouting partial function over a 21-day observation period (Figure
response to injury in the nogo-A/B/ mice. 6H). The BBB scores of nogo-A/B/ mice are signifi-
cantly higher than controls throughout the 2–21 day
period. While it is possible that the early (2 day) im-Corticospinal Axon Regeneration after SCI
provement is due to some long-distance growth of CSTin nogo-A/ Mice
fibers extending from the lesion site to the lumbar motorWhile CST fibers sprout extensively above a thoracic
pool, it seems much more probable that this is due tohemisection in nogo-A/B/ mice, a more critical issue
short-range sprouting of partially injured tracts such asis whether such fibers project to the caudal spinal cord
the raphespinal system in the ventrolateral portions ofbelow the injury. Examination of longitudinal sections
the cord (see Discussion). At the 17-day time point, theacross the SCI demonstrate that many fibers do regener-
higher scores of nogo-A/B/ mice might be attributableate across the injury site and can be seen to follow
to both the long-distance CST regeneration seen bya branching trajectory in distal gray and white matter
BDA tracing and to local sprouting in the lumbar cord.(Figures 5A and 5B). The tortuous trajectory is distinct
By this time point, functional recovery from dorsal hemi-from rostral fibers in control animals, which have a linear
section is nearly complete (GrandPre´ et al., 2002). Re-profile in the dCST (Figures 5E and 5F). It is also clearly
gardless of mechanism, the locomotor recovery in thedistinct from the linear trajectory of caudal uninjured
nogo-A/B/ mice is significantly greater than in controlfibers in wild-type animals with a more shallow injury
animals.that does not disrupt the entire dCST (not seen in this
study but observed in pilot experiments; data not
shown). As further validation of the extent of the transec- Discussion
tion, staining for the astroglial marker, GFAP, demon-
strates that scar reaches deeper than the level of the Analysis of mice with a disruption in the nogo-A/B gene
has provided insights into the response of young adultdCST (Figures 5C and 5D). Camera lucida drawings of
all BDA-labeled fibers summarize the pattern of CST brain and spinal cord to trauma. The hypothesis that
Neuron
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Figure 3. Growth Cone Collapse and Neurite Outgrowth Assays Using Nogo-A/B-Deficient Myelin
(A) Growth cone collapse (upper panels) and neurite outgrowth (lower panels) assays. E12 chick DRG explants were treated with 1 ng/l CNS
myelin purified from either nogo-A/B/ or nogo-A/B/ brains for 30 min. Dissociated E12 chick DRG neurons were plated on dried spots of
CNS myelin (2 ng) purified from either nogo-A/B/ or nogo-A/B/ brains and incubated 5–7 hr. Scale bar equals 25 m for upper panels and
50 m for lower panels.
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myelin-derived Nogo-A participates in limiting CNS axon ist in the adult CNS, it is clear that perturbation of the
nogo gene is sufficient to allow a degree of axonal regen-regeneration is supported by several lines of evidence
eration. This study considers only SCI and CST axons;presented here. CNS myelin has greatly reduced in vitro
no other axons are considered. However, given theaxon inhibitory activity. Most importantly, after SCI, nu-
widespread distribution of Nogo in oligodendrocytesmerous axonal sprouts are observed in the spinal cord
and NgR in adult neurons (GrandPre´ et al., 2000; Fournierand long-distance CST regeneration is prominent. It ap-
et al., 2001; Wang et al., 2002a; Huber et al., 2002), itpears that Nogo-A plays a role in regulating axonal
seems likely that the regeneration of numerous othersprouting and plasticity in the young adult CNS. How-
pathways are subject to similar limitation by Nogo-A.ever, uninjured brain structure and function is largely
We speculate that other axonal pathways would exhibitnormal in the nogo-A/B/ mice.
long-distance regeneration after injury in the absence
of Nogo-A.Axonal Sprouting after Axotomy
All young adult nogo-A/B/ mice exhibited pro-in the nogo-A/B/ Mice
nounced CST axon sprouting proximal to the injury. Pre-In the adult mammalian CNS, injured axons exhibit little
liminary studies indicate that sprouting may be re-if any sprouting. In the nogo-A/B/ young adult mice,
stricted at older ages in the nogo-A/B/ mice. Furtherthe CST sprouts exuberantly after injury even though its
experiments are required to determine if there is a “criti-morphology appears normal in uninjured animals. Based
cal period” for robust axon regeneration in the nogo-A/on the in vitro inhibitory activity of Nogo-66 via an axonal
B/ mice.NgR (GrandPre´ et al., 2000; Fournier et al., 2001), the
simplest explanation would appear to be that Nogo-A in
Other Axon Regeneration Inhibitorswild-type oligodendrocytes inhibits axonal growth after
Among myelin constituents, Nogo-A accounts for theinjury. An alternative speculation based on a role for
vast majority of axon inhibition in vitro, based on theneuronal Nogo-A seems implausible since there is no
results presented here. CNS myelin lacking Nogo-A in-clear in vitro correlate and since neuronal Nogo-C ex-
hibits axon outgrowth in vitro weakly but is only aboutpression remains high in the nogo-A/B/mice and might
one-eighth as potent as wild-type myelin. The residualbe expected to produce compensatory effects. How-
axon inhibitory activity in nogo-A/B/ myelin may be
ever, genetic modifiers of the effects of oligodendrocyte
due to MAG, OMgp, and/or CSPGs. Anti-MAG antibody
Nogo-A deficiency may exist (see accompanying papers
experiments with nogo-A/B/ myelin support a role for
Zheng et al., 2003; Simonen et al., 2003 [in this issue of both Nogo-A and MAG in vitro. Nonmyelin CNS compo-
Neuron]). Since axonal CST sprouting does not occur nents, such as astrocyte scar-derived CSPGs, con-
in the absence of injury, an unidentified axotomy signal tactin, and Sema3A, have been implicated as CNS axon
that has the capacity to induce a sprouting response regeneration inhibitors based on various assays (re-
must be suppressed by Nogo-A signaling under normal viewed by Fournier and Strittmatter, 2001; Fawcett and
conditions. In a CNS devoid of Nogo-A or in a peripheral Asher, 1999). The relative contribution of these mole-
nerve transplant, this signal becomes capable of ex- cules is not considered here, but it is clear that a degree
erting its positive effect on axonal growth. of CST axon growth can occur in young adult nogo-A/
B/ mice capable of expressing these other factors.
Long-Distance Axonal Regeneration Perhaps such nonmyelin factors require Nogo-A func-
in the nogo-A/B/ Mice tion synergistically to limit axonal regeneration by a mul-
Axonal sprouting is associated with long-distance re- tifactorial mechanism. Loss of either Nogo-A function
generation of CST axons in the nogo-A/B/ mice. Hun- or that of nonmyelin axon regeneration inhibitors might
dreds of CST fibers are detectable millimeters caudal allow extensive axonal regeneration. Such a notion is
to the injury site of mutant mice within weeks of a SCI. supported by recent results with chondroitinase ABC
This degree of axonal regeneration compares favorably delivery to SCI sites (Bradbury et al., 2002) and by micro-
to olfactory ensheathing cell transplant studies (Ramo´n- transplant studies (Davies et al., 1999). There is also
Cueto et al., 2000). Perhaps not surprisingly, the extent preliminary evidence that age may affect sprouting. In
of regeneration exceeds that achieved by pharmaco- the nogo-A/B/ mice, CST sprouting may occur only
logic or immunologic blockade of Nogo action when SCI occurs at the young adult stage.
(GrandPre´ et al., 2002; Bregman et al., 1995; Hauben et
al., 2001). This might be due to the mutation altering both Guidance of Regenerating Axons
Amino-Nogo and Nogo-66 function in oligodendrocytes. The CST exhibits both collateral sprouting rostral to the
cord lesion and long-distance growth into caudal cordWhile other limitations to axonal regeneration might ex-
(B) Quantitation of growth cone collapse in E12 chick DRG explants treated with soluble myelin extracts derived from brains of nogo-A/,
nogo-A/, and nogo-A/B/ mice.
(C) Quantitation of neurite outgrowth in dissociated E12 chick DRG neurons plated on dried spots of myelin extracts derived from brains of
nogo-A/B/ and nogo-A/B/ mice.
(D) Neurite outgrowth from adult mouse DRG or P8 cerebellar neurons placed on spots of myelin from nogo-A/B/ or nogo-A/B/ mice
(DRG, 2 ng myelin, cerebellar, 35 ng myelin).
(E) Neurite outgrowth from chick E12 DRG cultured on 10 ng spots of myelin from nogo-A/B/ or nogo-A/B/ mice in the presence of PBS,
25 g/ml control IgG, or 25 g/ml of anti-MAG.
All data are represented as mean  SEM. Single asterisk, significantly different from wild-type, p  0.01; double asterisk, significantly different
from wild-type/PBS, p  0.05; triple asterisk, significantly different from / PBS, p  0.05 (Student’s t test).
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Figure 4. CST Fiber Sprouting Rostral to the Lesion in nogo-A/B/ Mice
(A and B) T3 crosssections of spinal cord from nogo-A/B/ and nogo-A/B/ mice, respectively, 21 days post injury 5 mm rostral to the
transection. The BDA-injected cerebral cortex corresponds to the left of these sections, so the major crossed dCST is on the right. Arrows
indicate ectopic CST fibers ipsilateral to the injection site in (B).
(C) Coronal sections of the BDA injection site from two nogo-A/B/ mice. The left cerebral cortex injection and projections to the capsular
system and across the corpus callosum to the contralateral hemisphere are visualized. Spinal cord segments from the same animals are
shown in (D) and (E).
(D) Labeled CST fibers in lateral funiculus ipsilateral to the BDA injection from two nogo-A/B/ mice. Scale bar equals 100 m (D and E).
(E) Labeled CST fibers near the midline of the spinal cord and 5 mm rostral to a hemisection from two nogo-A/B/ mice. The heavily labeled
contralateral dCST is seen to the right of the midline (gray arrowhead). The arrows indicate CST fibers crossing the midline in the gray matter
ventral to the dorsal columns.
(F) Labeled lateral column CST fibers 5 mm rostral to lesion ipsilateral or contralateral to the BDA injection with or without SCI in nogo-A/
B/ (n  8) and nogo-A/B/ (n  15) mice. Single asterisk, values significantly different from corresponding / value.
(G) The optical density of HRP labeling of BDA-traced CST fibers in the lateral columns from sections such as (A) and (B).
(H) Ectopic CST sprouting outside the dCST in nogo-A/B/ mice at different levels of the spinal cord. Single asterisk, values significantly
different from T3 value.
All data are represented as mean  SEM. Significance, *p  0.05; **p  0.01 versus control (Student’s t test).
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Figure 5. Long-Distance CST Regeneration and Sprouting in Nogo-A/B Knockout Mice
(A and B) Parasagittal sections of spinal cord containing lesion sites (arrowheads) in two different nogo-A/B/ mice. Numerous branching
axons extend into the caudal spinal cord segment. Minor cavitation and phagocytic cells in the lesion site are seen. Rostral is to the left and
dorsal is up. Scale bar equals 200 m.
(C and D) Parasagittal sections demonstrating GFAP staining around the injury site in two nogo-A/B/ mice.
(E–K) Camera lucida drawings of all BDA-labeled CST axons in all consecutive parasagittal sections from a 1 cm section of the thoracic spinal
cord containing the hemisection. The genotype of the mice is indicated. Based on the transverse section data of Figure 6 below, many of the
caudal fibers are present in lateral white matter regions.
segments in the nogo-A/B/ mice. While the overall pyramidal decussation that CST axons create during
the late embryonic period, so that many CST fibers aretrajectory of this growth appears to be caudal, the CST
is remarkably different than in its preinjury state. Above seen ipsilateral to the cortical injection site. The molecu-
lar cues driving collateral CST sprouts to recross thethe hemisection, most collateral CST fibers project
across the midline and assume a nonfasciculated lateral midline in hemisected nogo-A/B/ mice have not been
delineated. The L1 adhesion molecule has a role in creat-position in the white matter. This crossing reverses the
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Figure 6. CST Fiber Sprouting Below the Lesion and Improved Functional Recovery in Nogo-A/B Knockout Mice
(A–C) Crosssections of spinal cord at L1 from nogo-A/B/ and nogo-A/B/ mice, 21 days post-SCI. Arrows indicate labeled CST fibers in
(B) and (C).
(D) Labeled CST fibers in lateral white matter from a nogo-A/B/ mouse.
(E) Labeled CST fibers in gray matter from a different nogo-A/B/ mouse than in (D).
(F) Quantitation of labeled CST fibers found in white and gray matter from nogo-A/B/ (n  8) and nogo-A/B/ mice (n  15), 5 mm caudal
to lesion.
(G) The optical density of HRP labeling of BDA-traced CST fibers in the lateral columns from sections such as (A)–(C).
(H) Comparison of open-field locomotor activity in nogo-A/B/ (n  19) and nogo-A/B/ (n  20) mice. All data are represented as mean 
SEM. Single asterisks indicate p 	 0.05 and double asterisks indicate p 	 0.001 versus nogo-A/B/ (Student’s t test).
ing the pyramidal decussation during development of growth in the spinal cord. However, there is clear evi-
dence that EphA4 receptors on CST axons respond tothe mouse and human CNS (Cohen et al., 1998), but it
does not appear to function in maintaining laterality a spinal cord midline Ephrin B3 barrier to prevent CST
recrossing during development (Kullander et al., 2001;within the cord. While both the Slit and Netrin proteins
have prominent roles in midline repulsion and attraction Leighton et al., 2001; Yokoyama et al., 2001). It is not
known whether EphA4 and Ephrin B3 are expressed infor other pathways, they are not known to regulate CST
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fully mature or injured spinal cord. It seems plausible Conclusions
Nogo-A appears to be a signficant axon growth inhibitorthat either EphA4 or Ephrin B3 is downregulated and that
in young adult CNS myelin. In the mice with a mutationthis fact contributes to collateral CST fiber recrossing in
in the nogo gene that prevents Nogo-A/B expression,injured nogo-A/B/ mice.
the nervous system is largely normal but responds toBelow the hemisection, regenerating CST fibers follow
injury in a unique fashion, with robust axonal sproutinghighly branched and perhaps random courses, populat-
and long-distance growth. While Nogo-A/B deficiencying both gray and white matter throughout the cord.
is partially responsible for the effect of this mutation,Here, axonal guidance is only apparent in the overall
other uncharacterized genetic factors may influence itscaudal course of fibers. There is no evidence for topo-
expression (see accompanying papers Zheng et al.,graphic organization within the cord, so that this aspect
2003; Simonen et al., 2003). Axon guidance for regener-of developmental axon guidance is not recapitulated
ating fibers is clearly not as precise as for developingduring long-distance regeneration of the CST in Nogo-
fibers. Nonetheless, spinal-injured nogo-A/B/ miceA-deficient spinal cord. It is also notable that the caudal
perform better in the open field than do control mice.fibers regenerating from the injured end of the CST axon
do not follow the same recrossing trajectory as do the
Experimental Proceduresrostral collateral sprouts. Of course, guidance to and
synapse formation with the appropriate lumbar moto-
Generation and Maintenance of Nogo-A/B Mutant Mice
neurons is the most critical aspect of axon guidance. A nogo-targeted embryonic stem (ES) cell clone was identified from
While some BDA-labeled synapse-like profiles in the the OmniBank Sequence Tag database (OST 45048, Lexicon Genet-
lumbar ventral horn were observed in this study (data ics, Inc.). The OmniBank mutations are created using insertional
mutagenesis based on retroviral-based gene trap methodologynot shown), investigation of this issue will require topo-
(Zambrowicz et al., 1998). Heterozygotic mice harboring the dis-graphic mapping of multiple discrete groups of regener-
rupted allele were bred to C57 Bl/6 mice for colony expansion inating fibers in chronically injured nogo-A/B/ mice com- our animal housing facility and intercrossed to maintain the nogo-
bined with ultrastructural analysis. A/B mutation on a hybrid 129/SvEvBrd 
 C57 Bl/6 background. In
the experiments here, animals had been backcrossed to C57BL/6
for 3–6 generations and 7- to 14-week-old nogo-A/B/ or nogo-A/
B/ littermates were used as controls for all experiments. In all inFunctional Recovery of Locomotion after SCI
vitro and behavioral assays, investigators were unaware of theAfter midthoracic dorsal hemisection, wild-type mice
mouse genotypes at the time of measurements.
recover a proportion of open-field locomotor perfor-
mance over several weeks. This recovery is accelerated
Southern and Northern Analyses
in nogo-A/B/ mice and is most dramatic at times as For Southern blot analysis, tail DNA was extracted using the DNeasy
early as 2 days post injury. Most likely, increased axonal Tissue Kit (Qiagen). Ten micrograms of DNA was digested with Nhe
growth is responsible for the improved locomotor I, electrophoresed into an agarose gel, and blotted onto a nylon
membrane. After UV-crosslinking, the membrane was hybridizedscores. It is not as clear which fiber tracts are responsi-
with random-primed 32P-labeled nogo probes at 42C in a 50% for-ble. The dCST does exhibit long-distance regeneration,
mamide/5
 SSPE/10% dextran sulfate/1% SDS solution andand this might possibly contribute to functional locomo-
washed at 62C with 0.1
 SSC/0.1% SDS. Genotypic screening was
tor recovery during the 1–3 week period. However, at 2 performed by PCR (nogo-A-specific forward primer, 5-ATTATG
days post injury, the functional improvement is likely to GATTTGATGGAGCAGCCAGGTAAC-3; nogo-A-specific reverse
primer, 5-CATCTGTTTTGTTTTCTGAAGTGTGATCTTC-3; virus-be due instead to collateral sprouting in the lumbar cord
specific reverse primer, 5-CAAGGAAACCCTGGACTACTGCGC-3).from other, partially injured, tracts. This argument is
For Northern blots, total brain RNA was isolated using the RNeasybased in part on the fact that regeneration under optimal
Midi Kit (Qiagen). Thirty micrograms of total RNA was separated on
circumstances in the sciatic nerve proceeds at 2 mm/ a 1% agarose/2% formaldehyde/1
 MOPS gel, blotted to a nylon
day, and the distance from the hemisection to the lumbar membrane, UV-crosslinked, and hybridized using 32P-labeled
probes. The 5 nogo-A probe corresponds a region in exon 1 encod-motor pool is 5–10 mm in these animals. The raphespinal
ing aa 30–145. The 3 nogo probe corresponds to a nogo-A cDNAsystem is widely distributed in the cord and is only par-
sequence encoding aa 1013–1162 and detects all endogenous nogotially injured in the hemisection model (Bregman et al.,
isoforms equally. The ngr probe is from a full-length mouse cDNA.
1995; Saruhashi et al., 1996; GrandPre´ et al., 2002). A Hybridization was performed using the NorthernMaxTM kit according
role for the raphespinal system in locomotor pattern to the manufacturer’s instructions (Ambion).
generation has been documented (Saruhashi et al.,
1996), and both IN-1 antibodies (Bregman et al., 1995; Immunoblotting
Bandtlow and Schwab, 2000) and NgR peptide antago- Brain or lung tissue was homogenized in RIPA buffer (1% Triton
X-100/0.5% sodium deoxycholate/0.1% SDS/1
 PBS) supple-nists (GrandPre´ et al., 2002) promote 5-HT fiber sprout-
mented with 1
 protease inhibitor cocktail mix (Roche) and soni-ing. Furthermore, similar early improvement in BBB
cated, and the supernatant was collected after centrifugation. My-scores after dorsal hemisection have been also ob-
elin protein was prepared (Norton and Poduslo, 1973) and extracted
served in studies with IN-1 antibodies (Merkler et al., with 2% octylglucoside before dialysis against PBS. Thirty micro-
2001) and with NgR peptide antagonist (GrandPre´ et al., grams of brain lysate or seven micrograms of myelin extract was
separated by SDS-PAGE and blotted onto PVDF. Affinity-purified2002). Therefore, collateral sprouting of the raphespinal
rabbit antibodies against Nogo-A was used at 50 ng/ml (Wang etsystem in the distal cord is a plausible mechanism for
al., 2002a), and antibodies detecting an amino-terminal peptide ofthe early recovery of nogo-A/B/ mice. Rearrangements
Nogo-A/B were diluted to 400 ng/ml (N-18; Santa Cruz Biotechnolo-
of other descending tracts, such as the rubrospinal sys- gies). Goat anti-MAG (Sigma) and rabbit anti-MBP (Zymed) antibod-
tem, or of distal intrinsic spinal cord circuitry might also ies were diluted 1:1000 and 1:10, respectively. Immunoreactivity
was visualized after incubation with biotinylated secondary antibod-contribute.
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ies and avidin-AP (Vector Laboratories) using NBT/BCIP AP sub- Acknowledgments
strates.
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